Cardiovascular and central nervous system effects of parenterally administered single doses of procarbazine (NSC-77,213).
D000758:Anesthesia; D000818:Animals; D001565:Benzoates / Q000008:administration & dosage*; D002490:Central Nervous System / Q000187:drug effects*; D004285:Dogs; D004347:Drug Interactions; D004567:Electrodes, Implanted; D004837:Epinephrine / Q000494:pharmacology; D000882:Haplorhini; D006321:Heart / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006834:Hydrazines / Q000494:pharmacology; D007263:Infusions, Parenteral; D008251:Macaca; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D010477:Perfusion; D011344:Procarbazine / Q000008:administration & dosage / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D013997:Time Factors; D014439:Tyramine / Q000494:pharmacology; D014690:Venous Pressure / Q000187:drug effects
D001565:Benzoates; D006834:Hydrazines; D011344:Procarbazine; D012110:Reserpine; D011433:Propranolol; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine